Company intelligence / Profile preview

Seine&Marne Biopharma

Serris, Ile-de-France, Francelinkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Seine&Marne Biopharma is an active French biopharmaceutical company founded in January 2024 with headquarters in Serris (Ile-de-France). It operates as an SAS under President Malek Hossein Ahmadi Pour and focuses on pharmaceutical preparation manufacturing and R&D activities within France. Publicly available information does not indicate any advanced clinical programs or major partnerships at this time[2][3][5].

Industry: Biotech

Beyond the preview

Go deeper on Seine&Marne Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seine&Marne Biopharma.

Explore the full profile